SunGen Pharma Establishes Injectable Division and Form­s Manufacturing Relationship with GRAM

Loading...
Loading...

PRINCETON, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has entered into a Manufacturing Agreement ("Agreement") with Grand River Aseptic Manufacturing ("GRAM") to manufacture generic injectable pharmaceutical products.

"We are excited to work with GRAM on the manufacturing of these important injectable products, and are pleased to announce that we have successfully filed an injectable ANDA manufactured by GRAM. It is an antispasmodic and anticholinergic agent.  We expect our next ANDA manufactured by GRAM to be filed with US FDA by the end of 2019. The product is used in combination chemotherapy," said Dr. Isaac Liu, Co- CEO of SunGen Pharma, "SunGen continues to build a strong pipeline by combining our own products and those co-developed with partners around the world."

SunGen Pharma launched its first injectable product in August 2017.  The company expanded its injectable division in October 2017 through the acquisition of a privately held pharmaceutical company based in Monmouth Junction, New Jersey. It currently has more than thirty products in its pipeline, and it has more than fifteen co development, manufacturing and marketing partners in North America, Europe and Asia.   

"The relationship between SunGen and GRAM has been very productive and the companies continue working on additional products for future filings.  We are excited to support SunGen's efforts to fill specific needs in the pharmaceutical marketplace." said Thomas Ross, CEO of GRAM.

About SunGen Pharma LLC
SunGen Pharma, LLC is a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products. SunGen specializes in the development of oral solid extended release, topical and complex injectable products. SunGen has business partnerships with many North American, European and Asian based generic pharmaceutical companies to develop, manufacture, and sell pharmaceutical products around the world.

About Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing, Inc. (GRAM), a parenteral contract development and manufacturing organization, delivers customized solutions to meet clients' fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM's expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing.

Contact:

SunGen Pharma LLC 
Diana Chan
Office: (609) 606-1070
diana.chan@sungenpharm.com

Grand River Aseptic Manufacturing, Inc.
Val Dittrich
Office: (616) 678-2400 ext. 210
vdittrich@grandriverasepticmfg.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsContractsPress ReleasesGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...